Skip to product information
Request a Quote
Ausamics IverPure™ — High-Purity Research Compound
$29.00 AUD
Ausamics IverPure™ — High-Purity Research Ivermectin Compound
AuSaMicS Life Science™ | www.ausamics.com.au
Product Description
Cat. No. ASA-2050
For Laboratory Research Use Only Schedule 4 (Australia)
Catalog Number
AC-2050
CAS Number
70288-86-7
Purity
≥95.8%
Form
Crystalline Powder
Appearance
White to Off-White
Molecular Formula
C48H74O14
Molecular Weight
875.10 g/mol
Storage
2–8 °C
Overview
≥95.8% Purity
No additives. No fillers. Trusted by professionals.
Ausamics IverPure™ is a high-purity, research-grade macrocyclic lactone compound structurally related to ivermectin (CAS 70288-86-7). It is produced via fermentation of Streptomyces avermitilis and supplied as a white to off-white crystalline powder with a minimum purity of ≥95.8%.
The material consists predominantly of approximately 80% 22,23-dihydroavermectin B1a and 20% B1b, consistent with established compositional profiles. IverPure™ is manufactured without additives, fillers, or processing aids, supporting consistent chemical integrity for controlled laboratory research.
This compound is widely studied for its interaction with glutamate-gated chloride channels in invertebrate nerve and muscle cells. It is supplied strictly for laboratory research use only and is not approved for therapeutic or veterinary administration.
Key Features & Benefits
🧪
High Purity Material Minimum purity of ≥95.8% for controlled laboratory research applications.
🧬
Defined Composition Predominantly composed of B1a and B1b fractions consistent with established compositional profiles.
🚫
No Additives or Fillers Manufactured without additives, fillers, or processing aids.
🔒
Research-Only Supply Supplied strictly for lawful laboratory research use subject to applicable regulatory controls.
Typical Research Applications
🦠
Parasitology & Veterinary Pharmacology Research
- Mechanistic studies of antiparasitic compounds
- Glutamate-gated ion channel modulation
- Veterinary drug resistance investigations
🔬
Pharmacological & Comparative Studies
- Comparative studies of macrocyclic lactone compounds
- In vitro screening and pathway analysis
- Structure–activity relationship research
Product Specifications
Catalog NumberAC-2050 CAS Number70288-86-7 Purity≥95.8% FormCrystalline powder AppearanceWhite to off-white Molecular FormulaC48H74O14 Molecular Weight875.10 g/mol Primary CompositionApproximately 80% 22,23-dihydroavermectin B1a and 20% B1b
Storage & Handling
Storage TemperatureStore at 2–8 °C in a tightly sealed container Light / MoistureProtect from moisture and direct light HandlingHandle in accordance with standard laboratory safety protocols StabilityStable under recommended laboratory storage conditions
Regulatory Notice (Australia)
Poisons StandardClassified as a Schedule 4 substance under the Australian Poisons Standard ARTG StatusNot listed on the Australian Register of Therapeutic Goods (ARTG) Approved UseNot approved for human or veterinary administration Order AccessIf the Order Quantity field is disabled, please contact us with valid licence or exemption documentation Contact+61 412 520 598 | sales@ausamics.com
Regulatory Notice Sale may be refused where required regulatory compliance, licensing, exemption status, or lawful eligibility cannot be verified.
⚠ Intended Use & Compliance Statement For laboratory research use only. Not for human consumption. Not for veterinary, agricultural, diagnostic, or therapeutic use. Not intended for food, feed, or pharmaceutical administration.
Legal Disclaimer Buyers are responsible for ensuring compliance with all applicable local, state, and federal regulations. International customers must confirm import eligibility with their local customs and regulatory authorities prior to purchase. Ausamics does not support or facilitate off-label, unapproved, or unauthorized applications. Ausamics Pty Ltd reserves the right to refuse sale where regulatory compliance cannot be verified. All product descriptions are provided for informational purposes only and do not constitute endorsement of any specific use.
Safety Data Sheet
Ausamics IverPure™ — High-Purity Research Compound | Cat. AC-2050
SDS — GHS Format
SDS-AC-2050 | Rev. 1.0
Issue Date: March 2026
Section 1 — Identification
Product NameAusamics IverPure™ — High-Purity Research Compound Catalog No.AC-2050 CAS Number70288-86-7 Recommended UseLaboratory research use only SupplierAuSaMicS Pty Ltd, 31 Longview CT, Thomastown VIC 3074, Australia Emergency Contact+61 412 520 598 | sales@ausamics.com Emergency ServicesAustralia: 000 | Poisons Information Centre: 13 11 26
Section 2 — Hazard Identification
Important: This material is supplied as a regulated research compound. Avoid exposure and handle only by trained personnel using suitable laboratory controls.
Regulatory StatusSchedule 4 substance in Australia Intended UseFor laboratory research use only Prohibited UsesNot for human consumption. Not for veterinary, agricultural, diagnostic, therapeutic, food, feed, or pharmaceutical administration. Exposure ControlAvoid inhalation, ingestion, skin contact, and eye contact. Prevent dust generation.
Section 3 — Composition / Ingredients
| Component | Specification | Function / Notes |
|---|---|---|
| IverPure™ research compound | ≥95.8% | Active research material |
| Primary fraction | Approx. 80% | 22,23-dihydroavermectin B1a |
| Secondary fraction | Approx. 20% | B1b |
| Additives / Fillers | None | No additives, fillers, or processing aids |
Section 4 — First Aid Measures
Skin ContactWash thoroughly with soap and water. Remove contaminated clothing. Seek medical advice if symptoms develop. Eye ContactRinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Seek medical attention. InhalationMove person to fresh air. Seek medical advice if symptoms occur. IngestionRinse mouth. Do not induce vomiting unless directed by medical personnel. Seek urgent medical advice.
Section 5 — Fire-Fighting Measures
Suitable Extinguishing MediaWater spray, foam, dry chemical, or carbon dioxide Specific HazardsThermal decomposition may produce irritating fumes and carbon oxides Protective EquipmentUse self-contained breathing apparatus and standard fire-fighting PPE
Section 6 — Accidental Release Measures
Personal PrecautionsEvacuate unnecessary personnel. Avoid dust generation. Use appropriate PPE. Environmental PrecautionsPrevent release to drains, waterways, and the environment. Clean-Up MethodsCarefully collect spilled material using methods that minimize dust. Place into suitable sealed waste container for disposal according to regulations.
Sections 7–16 — Handling, Storage, PPE, Physical, Stability, Disposal, Transport, Regulatory
HandlingHandle only by trained personnel using standard laboratory controls and good hygiene practices. StorageStore at 2–8 °C in a tightly sealed container. Protect from moisture and direct light. PPELaboratory coat, suitable gloves, safety glasses, and dust control measures recommended. AppearanceWhite to off-white crystalline powder Molecular FormulaC48H74O14 Molecular Weight875.10 g/mol StabilityStable under recommended laboratory storage conditions DisposalDispose in accordance with applicable laboratory, hazardous waste, and local regulatory requirements TransportHandle and ship subject to applicable regulatory and customer eligibility requirements Prepared ByAuSaMicS Pty Ltd — Quality & Regulatory Affairs
Disclaimer This SDS-style content is provided in website format and should be aligned with your approved internal or regulatory safety documentation before publication where required.
Certificate of Analysis
Ausamics IverPure™ — High-Purity Research Compound | Cat. AC-2050
COA — Batch Specific
COA-AC-2050-L001
Issue Date: March 2026
Product Information
Product NameAusamics IverPure™ — High-Purity Research Compound Catalog No.AC-2050 CAS Number70288-86-7 FormCrystalline powder AppearanceWhite to off-white Storage2–8 °C, tightly sealed, protected from moisture and light
Lot / Batch Information
Lot NumberAC2050-L001 Manufacture DateMarch 2026 Expiry / Retest DateMarch 2029 Pack SizeTBD Regulatory NoteResearch use only; supply subject to regulatory verification ARTG StatusNot listed on ARTG
Analytical Test Results
| No. | Test / Criteria | Method | Specification / Limit | Result | Status |
|---|---|---|---|---|---|
| 1 | Appearance | Visual inspection | White to off-white crystalline powder | Conforms | PASS |
| 2 | Identification | Reference standard / approved method | Conforms to reference material | Conforms | PASS |
| 3 | Purity | Approved analytical method | ≥95.8% | 95.8%+ | PASS |
| 4 | Primary Composition Ratio | Approved analytical method | Approx. 80% B1a / 20% B1b | Conforms | PASS |
| 5 | Additives / Fillers | Manufacturing review | None present | None | PASS |
| 6 | Moisture / Handling Quality | Internal QC | Conforms to internal specification | Conforms | PASS |
Overall Batch Disposition
RELEASED — COMPLIES WITH SPECIFICATIONS
Authorisation
Analysed By
QC Analyst | AuSaMicS Pty Ltd
Date: _______________
Approved & Released By
Quality Manager | AuSaMicS Pty Ltd
Date: _______________
Disclaimer This Certificate of Analysis applies only to the batch identified above and reflects testing of a representative sample. Buyers and end users are responsible for verifying lawful eligibility, intended use, and regulatory compliance prior to purchase, import, handling, or use.